Genevac Launches new Information-rich Website
News Nov 27, 2007
Genevac has announced the launch of a new information-rich website. The new website, located at www.genevac.com, offers rapid navigation through Genevac's comprehensive range of evaporators, concentrators and partner products, their applications and background technologies.
Designed for drug discovery applications and in use in pharmaceutical research laboratories worldwide - Genevac evaporators range from the ultra compact EZ-2 Series Personal Evaporators and the HT Systems for benchtop applications to the ultra high throughput Mega Systems for production environments.
Combining ease of use and high performance the miVac concentrator range provide molecular biology laboratories with compact systems for removing water and organic solvents from a wide variety of sample formats. Partner products, from sister companies in the SP Industries Group, include freeze driers, chillers, coolers, glassware and washers.
Visitors to the site will be able to benefit from the experience of Genevac staff and customers in a series of new technical forum. Updated daily, each forum offers a selection of questions and answers to common technical, applications and operational issues relating to evaporation, sample concentration and lyophilization. Should user’s topic not be covered facility is given to start a new forum discussion theme.
In addition to offering access to application notes, articles and the latest news the new site provides background to the technologies behind Genevac's systems. Background information on the company, service and support, forthcoming events and representatives around the world is also provided.
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019